ArticleThe Australian & New Zealand journal of obstetrics & gynaecology2026
Indications for Micro-Injection of Sperm in Assisted Reproduction: A Consensus Statement.
Article in The Australian & New Zealand journal of obstetrics & gynaecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Indications for Micro-Injection of Sperm in Assisted Reproduction: A Consensus Statement.The Australian & New Zealand journal of obstetrics & gynaecology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following the first report of use of intracytoplasmic sperm injection (ICSI) in 1992 there has been a consistent global increase in the use of ICSI to fertilise human oocytes in vitro, though since 2016 there has been a small reduction in its use in Australia and New Zealand This consensus statement, developed by the subspecialty group in reproductive endocrinology and infertility, reviews the evidence underpinning the use of ICSI. It is concluded that ICSI is an appropriate intervention when there is reduced semen quality or if there is a significant risk of failed fertilisation, though the exact seminal parameters which predict appropriate use of ICSI are uncertain. ICSI is an appropriate intervention when there has been failed or poor fertilisation rates in a previous IVF cycle. ICSI may be used to reduce the risk of recurrent molar pregnancy, but the evidence to support its use after oocyte cryopreservation, in vitro maturation of oocytes (IVM), prior to preimplantation genetic testing (PGT) and when treating HIV sero-discordant couples is lacking, and these are areas requiring further research. ICSI is not necessary in unexplained infertility when a low number of oocytes have been retrieved during the treatment cycle or when the female age is advanced if the semen parameters are normal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.